valproic acid has been researched along with hydrogen sulfide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amadori, D; Arienti, C; Brigliadori, G; Carloni, S; Del Soldato, P; Fabbri, F; Pasini, A; Silvestrini, R; Sparatore, A; Tesei, A; Ulivi, P; Zoli, W | 1 |
1 other study(ies) available for valproic acid and hydrogen sulfide
| Article | Year |
|---|---|
Organosulfur derivatives of the HDAC inhibitor valproic acid sensitize human lung cancer cell lines to apoptosis and to cisplatin cytotoxicity.
Topics: Apoptosis; Cell Line, Tumor; Cisplatin; Drug Synergism; Histone Deacetylase 1; Histone Deacetylase Inhibitors; Humans; Hydrogen Sulfide; Lung Neoplasms; Mitochondria; Valproic Acid | 2012 |